Polymorphism of the MDR1/ABCB1 C3435T drug-transporter and resistance to anticonvulsant drugs: a meta-analysis.
about
A Prediction Algorithm for Drug Response in Patients with Mesial Temporal Lobe Epilepsy Based on Clinical and Genetic InformationA multi-system approach assessing the interaction of anticonvulsants with P-gpGenetic association analysis of ATP binding cassette protein family reveals a novel association of ABCB1 genetic variants with epilepsy risk, but not with drug-resistanceThe roles of variants in human multidrug resistance (MDR1) gene and their haplotypes on antiepileptic drugs response: a meta-analysis of 57 studiesDrug-Resistant Epilepsy: Multiple Hypotheses, Few AnswersPolymorphism of ABCB1/MDR1 C3435T in children and adolescents with partial epilepsy is due to different criteria for drug resistance - preliminary results.Corpora amylacea deposition in the hippocampus of patients with mesial temporal lobe epilepsy: A new role for an old gene?Influence of ATP-binding cassette polymorphisms on neurological outcome after traumatic brain injury.Clinically significant psychotropic drug-drug interactions in the primary care setting.PharmGKB summary: phenytoin pathway.Relationship between ABCB1 3435TT genotype and antiepileptic drugs resistance in Epilepsy: updated systematic review and meta-analysisExpression of ATP-Binding Cassette Transporters B1 and C1 after Severe Traumatic Brain Injury in Humans.CYP3A5*3 and C3435T MDR1 polymorphisms in prognostication of drug-resistant epilepsy in children and adolescentsEpilepsy pharmacogenetics.Single nucleotide polymorphisms of ABCB1 gene and response to etanercept treatment in patients with ankylosing spondylitis in a Chinese Han population.Management of the patient with medically refractory epilepsy.ABC transporters in drug-refractory epilepsy: limited clinical significance of pharmacogenetics?Transporter hypothesis of drug-resistant epilepsy: challenges for pharmacogenetic approaches.Association of ABCB1 gene polymorphisms and their haplotypes with response to antiepileptic drugs: a systematic review and meta-analysis.Pharmacogenetics of drug transporters in the enterohepatic circulation.Drug resistance in epilepsy and the ABCB1 gene: The clinical perspective.Pharmacogenomics and epilepsy: the road ahead.A systematic review and meta-analysis of the role of ABCC2 variants on drug response in patients with epilepsy.Understanding the spectrum of temporal lobe epilepsy: contributions for the development of individualized therapies.Association of MDR1 gene C3435T polymorphism with childhood intractable epilepsy: a meta-analysis.Genetic biomarkers in epilepsy.Polymorphisms of the drug transporters ABCB1, ABCG2, ABCC2 and ABCC3 and their impact on drug bioavailability and clinical relevance.Impact of Genetic Polymorphisms of ABCB1 (MDR1, P-Glycoprotein) on Drug Disposition and Potential Clinical Implications: Update of the Literature.The pharmacogenomics of epilepsy.Impact of Genetic Polymorphisms on Phenytoin Pharmacokinetics and Clinical Outcomes in the Middle East and North Africa Region.The effect of MDR1 C3435T polymorphism on the eradication rate of H. pylori infection in PPI-based triple therapy: A meta-analysis.Impact of Transporter Polymorphisms on Drug Development: Is It Clinically Significant?Pharmacogenomics in epilepsy.Biomarkers for antiepileptic drug response.PharmGKB summary: carbamazepine pathway.ABCC2 polymorphisms and haplotype are associated with drug resistance in Chinese epileptic patients.Unexpected Lower Expression of Oncoprotein Gankyrin in Drug Resistant ABCG2 Overexpressing Breast Cancer Cell LinesAssociations between MDR1 C3435T polymorphism and drug-resistant epilepsy in the Polish population.MDR1/ABCB1 polymorphisms and multidrug resistance in epilepsy: in and out of fashion.Pilot study examining the frequency of several gene polymorphisms involved in morphine pharmacodynamics and pharmacokinetics in a morbidly obese population.
P2860
Q28468396-2B2E9B71-23E9-42E2-8F92-DB273BD6FE67Q28533527-978EB66F-0315-48A9-97C3-692EFFC5AB46Q28540047-CD3ADC28-6CFC-40CD-90EE-F2B3E5282D90Q28545116-8E051648-7BED-401B-A020-8B72B39F9CDAQ33875271-8C6120DC-2CF4-43C8-B4E2-096A95A2BFF6Q34237989-9723AE95-ABA9-439D-8021-00D6B2500806Q35073485-5DBFC629-DFE2-4818-AAF9-E61343FDA1FCQ35095391-D331D553-4BEE-44C5-8153-6D388523A770Q35104220-CD3AA93D-0CB7-420A-BF72-609B07EA6534Q35950546-A1BFDF85-A5D0-47F3-9972-4AEB73E529ACQ36281662-97470918-80EE-4675-A8A9-13F92FC26FEAQ36489564-0A1870CE-AAE5-4BBC-895A-4378FAB5821CQ37104987-DF3B9337-5EC6-4AC2-ACB4-255FDCD360B3Q37486720-9FD6EE00-E044-4A62-A3B6-DCB0DA7CDD24Q37626601-083B61BF-7312-41DB-8FCC-5B87332BBDCBQ37642003-5D561F75-0A02-4E81-B3EA-A11131BE318CQ37658265-407C4525-88D2-4132-9C74-B510B2CB668FQ37806763-B79B5616-E7A3-43E1-8D10-86E5D10098FDQ37851513-3FCC08CE-D5F9-49B9-9AA2-4560B449AE78Q37880875-FE4071A2-1D01-42E5-9EB2-4E34B73B353AQ37900131-A314BCDE-C0C0-432B-99D3-24F88B435BF6Q37946957-BBDE9154-A416-4392-A95F-6C4FE344F269Q38090733-B910FB6A-DA3A-4F04-9B40-837D76899D8BQ38162945-4DAC4B6B-A801-40BE-9621-BA40654E7364Q38189656-20F0D8C8-CF2A-41C9-85C8-721603FD33DDQ38190879-28289611-71DA-4154-A019-3B33C50BAFBBQ38243832-06FEECA1-E691-48A6-914E-74DC5C6F8895Q38414396-BABFE05D-64FF-4F65-B898-DE61128AF2E5Q38577986-878198A0-463C-4F7E-86A9-2FE0C1E3D694Q38651234-BD8AB24B-8866-4D9B-B15C-877F6C68C1A1Q38738159-68D16376-5F68-44F3-A64D-A0E78DF999D7Q38888369-8B912371-B9DC-4463-8724-4CD431166EBEQ39084353-3B3944F8-F6AE-4853-9075-8ECA475FD7ACQ40575037-EA2B9BFB-9592-4BFB-8C29-90D8B026ECC2Q42157342-DC276667-F934-4EA7-AC55-230817B060EAQ43903895-1B10B18B-04A8-41DE-B48E-730D1B0C41C4Q47245509-F2E91134-7C24-44B6-BCA3-42E7A5A86746Q47712409-0D60C81D-118C-437E-BE8A-3406ABAD880CQ47778603-9A472BB3-9801-4B12-9201-0FDC50E7E6EFQ48364253-B90A9C87-A402-4431-BFD9-709CD9565507
P2860
Polymorphism of the MDR1/ABCB1 C3435T drug-transporter and resistance to anticonvulsant drugs: a meta-analysis.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Polymorphism of the MDR1/ABCB1 ...... ulsant drugs: a meta-analysis.
@en
Polymorphism of the MDR1/ABCB1 ...... ulsant drugs: a meta-analysis.
@nl
type
label
Polymorphism of the MDR1/ABCB1 ...... ulsant drugs: a meta-analysis.
@en
Polymorphism of the MDR1/ABCB1 ...... ulsant drugs: a meta-analysis.
@nl
prefLabel
Polymorphism of the MDR1/ABCB1 ...... ulsant drugs: a meta-analysis.
@en
Polymorphism of the MDR1/ABCB1 ...... ulsant drugs: a meta-analysis.
@nl
P2093
P1433
P1476
Polymorphism of the MDR1/ABCB1 ...... ulsant drugs: a meta-analysis.
@en
P2093
David N Juurlink
Facundo Garcia Bournissen
Gideon Koren
Mugabe Walker
Myla E Moretti
Yaron Finkelstein
P304
P356
10.1111/J.1528-1167.2008.01858.X
P577
2008-10-24T00:00:00Z